Premium
Should providers prescribe sacubitril/valsartan based on trial eligibility, approval indication, or guideline recommendations?
Author(s) -
Ambrosy Andrew P.,
Fudim Marat,
Chioncel Ovidiu
Publication year - 2019
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1002/ejhf.1555
Subject(s) - medicine , sacubitril, valsartan , guideline , valsartan , sacubitril , medline , family medicine , intensive care medicine , pathology , political science , blood pressure , law